Home Selerant - Food Regulatory News FSANZ Issues Use of Enzymes Maltogenic alpha-amylase from a GM Strain of E. coli FSANZ Issues Use of Enzymes Maltogenic alpha-amylase from a GM Strain of E. coli Dec 1, 2021 Posted By: Benoit Gruber Share: On November 30th, 2021, Food Safety Australia and New Zealand sought approval on “Calls for submission on a new processing aid from a GM source”. The use of the enzyme maltogenic alpha-amylase from a GM strain of Escherichia coli. The scope of the document highlights the following: The enzyme will be permitted for use as a processing aid in baking, brewing, and starch processing; The assessment found no health or safety concerns for consumers at the proposed usage levels; In these food processing applications, the maltogenic alpha-amylase has a technological function during food processing and not in the final food; The production organism has a history of safe use for food-grade enzyme production and is not known to produce any toxic metabolites. The draft is open for public consultation period until January 18th, 2022. To view the document, check out the Food News Monitoring System and stay up-to-date with the latest regulatory requirements.